mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.004 |
mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.004 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
mRNA |
TKI258 |
CCLE |
pan-cancer |
AAC |
-0.14 |
0.006 |
mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.007 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.008 |
mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.008 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.01 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.15 |
0.01 |